Governor Nathan Deal of Georgia and Governor Bill Haslam of Tennessee have both signed biosimilar legislation into law. Arthritis Foundation Advocates actively lobbied for both bills, meeting with legislators, testifying at hearings, writing letters, making phone calls and working to put patient safety issues associated with biosimilars in front of the media.
The legislation will allow biosimilar medicines to be marketed in these states. The new laws also require notifying patients and prescribers when biosimilars are dispensed instead of biologics. Biologics have been vital for people with arthritis – increasing mobility, reducing pain and improving overall quality of life.